drugset / Trial / NCT00111150
Botswana Tenofovir Oral HIV Prophylaxis Trial
Phase 2/3
Terminated
1200 enrolled
Centers for Disease Control and Prevention
Botswana Ministry of Health · collabGilead Sciences · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will test whether taking a pill of tenofovir (an antiretroviral medicine) is safe for sexually-active young adults in Botswana without HIV infection and whether it will reduce their risk of getting an HIV infection.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2007-03
Outcome
Outcome not reported
Stopped: “Consenting participants entered tenofovir/emtricitabine oral prophylaxis trial”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir disoproxil fumarate | Small molecule | 300 mg | Oral |